Last updated 7 months ago

Efficacy and Safety of GSK4527226 [AL101] in Participants With Early Alzheimer's Disease

282 patients around the world
Available in Spain, Argentina, United States
GlaxoSmithKline
282Patients around the world
This study is for people with
Alzheimer disease
Requirements for the patient
To 85 Years
All Gender
Medical requirements
Trialtech
About usOur missionOur teamPartnersFAQs
Medical newsLatest newsStudiesInterviewsTestimonials
ProductsUEPM OncoUEPM Physicians
LinksDownloads
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy